Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Liebrich

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|May 1, 1991
A new human colon carcinoma lineW Liebrich, S Gonser, S Brüderlein, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccineB Lehner, P Schlag, W Liebrich, et al.
Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology|September 1, 1995
Cadmium-binding proteins from a tunicate, Pyura stoloniferaW Liebrich, A C Brown, D P Botes
Chromosoma|August 1, 1989
A group of non-Y encoded Drosophila hydei primary spermatocyte nuclear glycoproteins exhibits epitopes depending on formation of Y chromosomal giant lampbrush loopsG Tischendorf, W Liebrich, P Trapitz, et al.
Annals of the New York Academy of Sciences|August 12, 1993
Specific immunotherapy of colorectal carcinoma with Newcastle-disease virus-modified autologous tumor cells prepared from resected liver metastasisV Schirrmacher, P Schlag, W Liebrich, et al.
Cancer|October 1, 1990
Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent Newcastle disease virusW Bohle, P Schlag, W Liebrich, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1995
[Significance of serum beta-hCG as a tumor marker for stomach carcinoma]B Rau, C Below, W Haensch, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
In vitro and clinical characterisation of a Newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patientsW Liebrich, P Schlag, M Manasterski, et al.
Cancer|November 15, 1995
Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. A reevaluationY Cao, U R Karsten, W Liebrich, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trialP Schlag, M Manasterski, T Gerneth, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|May 1, 1991
A new human colon carcinoma lineW Liebrich, S Gonser, S Brüderlein, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccineB Lehner, P Schlag, W Liebrich, et al.
Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology|September 1, 1995
Cadmium-binding proteins from a tunicate, Pyura stoloniferaW Liebrich, A C Brown, D P Botes
Chromosoma|August 1, 1989
A group of non-Y encoded Drosophila hydei primary spermatocyte nuclear glycoproteins exhibits epitopes depending on formation of Y chromosomal giant lampbrush loopsG Tischendorf, W Liebrich, P Trapitz, et al.
Annals of the New York Academy of Sciences|August 12, 1993
Specific immunotherapy of colorectal carcinoma with Newcastle-disease virus-modified autologous tumor cells prepared from resected liver metastasisV Schirrmacher, P Schlag, W Liebrich, et al.
Cancer|October 1, 1990
Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent Newcastle disease virusW Bohle, P Schlag, W Liebrich, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1995
[Significance of serum beta-hCG as a tumor marker for stomach carcinoma]B Rau, C Below, W Haensch, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
In vitro and clinical characterisation of a Newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patientsW Liebrich, P Schlag, M Manasterski, et al.
Cancer|November 15, 1995
Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. A reevaluationY Cao, U R Karsten, W Liebrich, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trialP Schlag, M Manasterski, T Gerneth, et al.
Pageof 2